Filter your results
- 4
- 4
- 697
- 26
- 18
- 13
- 2
- 1
- 4
- 2
- 1
- 1
- 3
- 1
- 4
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Combining RAIT and immune-based therapies to overcome resistance in cancer? Combining RAIT and immune-based therapies to overcome resistance in cancer?Resistance to Ibritumomab in Lymphoma, 18, pp 119-137, 2018, ⟨10.1007/978-3-319-78238-6_9⟩
Book sections
inserm-02338494v1
|
||
|
Thérapie cellulaire T adoptiveImmunothérapie des cancers au troisième millénaire, EDP Sciences, pp.217-228, 2015, 978-2759811106
Book sections
inserm-02537891v1
|
||
|
IN : Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms Ms no. 5311: Title : Thoracic Neoplasia-Mesothelioma AuthorsPathobiology of Human Disease, 5311, Elsevier, pp.2690-2700, 2014, IN : Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms, ⟨10.1016/B978-0-12-386456-7.05311-9⟩
Book sections
inserm-02479972v1
|
||
|
Prospects for Enhancing Efficacy of RadioimmunotherapyResistance to Ibritumomab in Lymphoma, pp.139-153, 2018, ⟨10.1007/978-3-319-78238-6_10⟩
Book sections
inserm-02315459v1
|